Regulatory Disclaimer

Important Notice

This Regulatory Disclaimer applies to all content, information, materials, and communications provided by ReGrowth Biotech Limited ("ReGrowth," "we," "us," or "our") through our website at www.regrowthbio.com (the "Website"), including all text, graphics, images, videos, publications, presentations, and other materials.

PLEASE READ THIS DISCLAIMER CAREFULLY. BY ACCESSING OR USING THE WEBSITE, YOU ACKNOWLEDGE AND AGREE TO THE TERMS SET FORTH IN THIS DISCLAIMER.

Not Medical Advice

General Information Only

THE CONTENT ON THIS WEBSITE IS PROVIDED FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT.

All content, including but not limited to text, graphics, images, articles, research summaries, treatment descriptions, and other materials on the Website, is for general informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of the Website and any communication with ReGrowth through the Website, including submission of enquiry forms, email correspondence, or participation in consultations, does not establish a doctor-patient, therapist-patient, or any other healthcare professional-patient relationship.

Information provided through the Website cannot replace the relationship between a patient and their own physician or healthcare provider. We do not provide medical consultations, diagnoses, or treatment recommendations through the Website.

Consult Healthcare Professionals

Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition, treatment options, or health concerns.

Never disregard professional medical advice or delay seeking medical treatment because of information you have read on the Website. If you believe you have a medical emergency, call your physician or emergency services immediately.

ReGrowth does not recommend or endorse any specific tests, physicians, healthcare providers, products, procedures, opinions, or other information that may be mentioned on the Website.

Treatment Availability and Regulatory Status

Regional Variations

Treatment availability, regulatory approval status, clinical protocols, and service provision vary significantly by country, region, and jurisdiction. Information provided on the Website may reference:

• Treatments, technologies, or services that are not available in your jurisdiction
• Treatments that have regulatory approval in some jurisdictions but not others
• Clinical protocols that differ from those applicable in your region
• Research or investigational treatments not yet approved for clinical use

The discussion of any treatment, technology, or service on the Website does not imply that such treatment is available, approved, or appropriate for use in your specific location.

China Market Focus

ReGrowth's D.P.G. (Dermal Papilla Growth) cellular hair restoration technology is currently approved and actively treating patients in China through our network of authorised clinical facilities. The treatment has undergone regulatory review and approval processes specific to the Chinese market.

International Market Status

For jurisdictions outside China, including but not limited to the United States, European Union member states, United Kingdom, Australia, Canada, and other regions:

• D.P.G. technology may be in various stages of regulatory review, clinical development, or not yet submitted for regulatory approval
• Treatment protocols may differ from those used in China
• Clinical availability may be limited or non-existent
• Additional regulatory approvals, clinical trials, or authorisations may be required before treatment becomes available

No Representation of Approval

Unless explicitly stated otherwise with specific reference to a particular jurisdiction, information on the Website does not constitute a representation that any treatment has been approved by regulatory authorities in your country or region.

Do not assume that treatments described on the Website are legally available, approved for use, or appropriate for your specific medical situation based solely on information provided here.

Verification Required

If you are interested in treatment availability in your jurisdiction, contact us directly at info@regrowthbio.com to:

• Confirm current regulatory status in your country or region
• Understand specific treatment protocols applicable to your jurisdiction
• Determine whether treatment is available and appropriate for your circumstances
• Receive guidance on consultation processes and requirements

Individual Results and Outcomes

No Guarantees

INDIVIDUAL RESULTS MAY VARY SIGNIFICANTLY. NO GUARANTEES, REPRESENTATIONS, OR WARRANTIES ARE MADE REGARDING TREATMENT OUTCOMES, EFFICACY, SAFETY, OR RESULTS.

Information about treatments, including success rates, improvement percentages, patient outcomes, and clinical data, represents general findings from research studies, clinical trials, or aggregate patient experiences. Such information:

• Reflects outcomes in specific populations under specific conditions
• May not be representative of results any individual patient will achieve
• Cannot predict or guarantee outcomes for any specific individual
• Does not account for individual variations in genetics, medical history, health status, treatment compliance, or other factors

Factors Affecting Outcomes

Treatment outcomes depend on numerous individual factors, including but not limited to:

• Severity and duration of hair loss condition
• Underlying causes of hair loss
• Overall health status and medical history
• Genetic factors and familial patterns
• Age and hormonal status
• Previous treatments and their effects
• Lifestyle factors and treatment compliance
• Individual cellular response to therapy
• Quality of donor tissue and cellular characteristics

Scientific Uncertainty

Cellular therapies, including D.P.G. technology, represent evolving areas of regenerative medicine. Scientific understanding continues to develop, and:

• Mechanisms of action may not be fully understood
• Long-term outcomes beyond current follow-up periods are not yet known
• Optimal treatment protocols continue to be refined
• Individual response variation requires further research

Forward-Looking Statements

The Website may contain forward-looking statements regarding:

• Future treatment availability and regulatory approvals
• Planned clinical trials or research studies
• Expected technological developments or improvements
• Anticipated market expansion or service launches
• Projected treatment outcomes or capabilities

Such forward-looking statements are based on current expectations and assumptions and involve risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied in forward-looking statements due to various factors, including regulatory decisions, clinical trial outcomes, technological challenges, market conditions, and other uncertainties.

Forward-looking statements speak only as of the date made and should not be relied upon as predictions of future events. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date made.

Research and Clinical Development

Investigational Status

Some treatments, technologies, or applications discussed on the Website may be:

• In research and development stages
• Undergoing preclinical or clinical investigation
• Part of ongoing clinical trials
• Not yet approved for clinical use in any jurisdiction
• Approved in some jurisdictions for specific indications but not others

Information about investigational treatments is provided for educational and research dissemination purposes and does not constitute an offer to provide such treatments.

Clinical Trial Information

References to clinical trials, research studies, or scientific publications are provided for informational purposes. Participation in clinical trials, where available, requires:

• Meeting specific eligibility criteria
• Informed consent processes
• Compliance with regulatory and ethical requirements
• Understanding of potential risks and benefits
• No guarantee of receiving investigational treatment (in placebo-controlled trials)

Contact us directly for information about clinical trial availability, eligibility requirements, and participation processes.

Treatment Risks and Considerations

Potential Risks

All medical treatments, including cellular therapies, carry potential risks, side effects, and complications. Potential risks may include but are not limited to:

• Allergic reactions or immune responses
• Infection at treatment sites
• Inflammation or swelling
• Pain or discomfort during or after procedures
• Bleeding or bruising
• Ineffective treatment or lack of desired results
• Unexpected adverse reactions
• Unknown long-term effects

The Website may not comprehensively describe all potential risks, side effects, or complications. Comprehensive risk disclosure occurs during individual medical consultations with qualified healthcare providers.

Contraindications

Certain medical conditions, medications, or circumstances may contraindicate treatment or require special precautions. Do not assume treatment is appropriate for you based solely on Website information.

Determination of treatment suitability, screening for contraindications, and assessment of risk factors require individual medical evaluation by qualified healthcare professionals.

Third-Party Content and Research

External Research

The Website may reference or summarise research studies, clinical trials, or scientific publications from academic institutions, research organisations, or other third parties. Such references:

• Are provided for educational and informational purposes
• Do not constitute endorsement of specific findings or conclusions
• May be simplified or summarised for general audience accessibility
• Should be verified by consulting original source materials
• Reflect the views and findings of original researchers, not necessarily ReGrowth's positions

Citations and Sources

Where scientific research is referenced, we endeavour to provide appropriate citations and source references. Users are encouraged to consult original publications for complete information, methodology details, and scientific context.

Third-Party Websites

Links to third-party websites, including research institutions, regulatory agencies, or medical organisations, are provided for convenience only. ReGrowth does not control, endorse, or assume responsibility for the content, accuracy, or practices of third-party websites.

Intellectual Property and Proprietary Information

Proprietary Technology

Information about D.P.G. technology, treatment protocols, cellular processing methods, and other ReGrowth proprietary technologies is provided for educational purposes only. Such information:

• May be protected by patents, trade secrets, or other intellectual property rights
• Does not constitute authorisation or license to use, reproduce, or implement such technologies
• Should not be relied upon for technical or clinical implementation without appropriate authorisation and training

Confidential Information

The Website may contain confidential or proprietary information about ReGrowth's technologies, methods, or business operations. Unauthorised use, reproduction, or disclosure of such information may violate intellectual property rights and contractual obligations.

Regulatory Compliance

Adherence to Regulations

ReGrowth is committed to compliance with applicable laws, regulations, and ethical standards in all jurisdictions where we operate, including:

• Medical device and cellular therapy regulations
• Healthcare service provision requirements
• Clinical trial and research ethics standards
• Advertising and marketing regulations for medical services
• Data protection and privacy laws

Reporting Obligations

If you experience adverse effects or unexpected outcomes following treatment with ReGrowth technologies, please report such events to:

1. Your treating physician immediately
2. ReGrowth at safety@regrowthbio.com
3. Applicable regulatory authorities in your jurisdiction as required by law

We maintain adverse event monitoring and reporting systems in compliance with regulatory requirements.

Financial and Investment Disclaimers

Not Investment Advice

Information on the Website about ReGrowth's business operations, market opportunities, growth projections, or financial matters is provided for general informational purposes only and does not constitute investment advice, financial advice, or solicitation to purchase securities.

Business Information

Statements regarding market size, growth rates, competitive positioning, or business strategy reflect ReGrowth's assessments based on available information and are subject to change. Such statements should not be relied upon for investment or business decisions without independent verification and professional advice.

Limitation of Liability

TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, REGROWTH DISCLAIMS ALL LIABILITY FOR:

• Reliance on information provided on the Website
• Medical decisions made based on Website content
• Treatment outcomes or results
• Adverse events or complications
• Regulatory changes affecting treatment availability
• Variations between Website information and actual treatment protocols
• Third-party content or research referenced on the Website

This disclaimer supplements and should be read together with the limitations of liability set forth in our Terms of Use.

Changes to This Disclaimer

We reserve the right to modify, update, or revise this Regulatory Disclaimer at any time. Material changes will be posted on the Website with an updated "Last Updated" date. Your continued use of the Website following such changes constitutes acceptance of the modified disclaimer.

Jurisdictional Notices

United States

If you are located in the United States, please note that D.P.G. technology has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). The treatment is not available for clinical use in the United States. Information on the Website is provided for educational purposes only and does not constitute an offer to provide treatment in the United States.

European Union

If you are located in the European Union, please note that regulatory approval status varies by member state and specific indications. Treatment availability and protocols differ from those in China. Contact us directly to confirm regulatory status and treatment availability in your specific EU member state.

United Kingdom

If you are located in the United Kingdom, please note that D.P.G. technology may not have received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or other applicable UK regulatory bodies. Treatment availability in the UK should be confirmed directly with ReGrowth.

Other Jurisdictions

For all other jurisdictions not specifically mentioned, treatment regulatory status and availability vary. Contact us directly at info@regrowthbio.com to confirm status in your specific country or region.

Contact Information

For questions regarding this Regulatory Disclaimer, treatment availability in your jurisdiction, regulatory status, or other matters:

ReGrowth Biotech Limited
Email: info@regrowthbio.com
Regulatory Enquiries: regulatory@regrowthbio.com
Safety Reporting: safety@regrowthbio.com
Website: www.regrowthbio.com

Governing Law

This Regulatory Disclaimer is governed by and construed in accordance with the laws of the Hong Kong Special Administrative Region, without regard to its conflict of law provisions.